![](/img/cover-not-exists.png)
Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–Small-Cell Lung Carcinoma
Hellerstedt, Beth A., Vogelzang, Nicholas J., Kluger, Harriet M., Yasenchak, Christopher A., Aftab, Dana T., Ramies, David A., Gordon, Michael S., Lara, PrimoLanguage:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2018.10.006
Date:
October, 2018
File:
PDF, 864 KB
english, 2018